» Articles » PMID: 20614287

Update on Nasopharyngeal Carcinoma

Overview
Specialties Oncology
Pathology
Date 2010 Jul 9
PMID 20614287
Citations 42
Authors
Affiliations
Soon will be listed here.
Citing Articles

Multimodal treatment according to the NPC-GPOH trials in adult patients with nasopharyngeal cancer-Analysis based on a single-center experience.

Leu M, Bohnenberger H, Guhlich M, Schirmer M, Pilavakis Y, Wolff H Cancer Rep (Hoboken). 2024; 7(8):e2111.

PMID: 39191673 PMC: 11349452. DOI: 10.1002/cnr2.2111.


Pedunculated Nasopharyngeal Mass: A Case of Squamous Cell Carcinoma.

Almutairi R, Almania A, AlHwiriny A, Sailan L Cureus. 2024; 16(6):e61917.

PMID: 38984013 PMC: 11230728. DOI: 10.7759/cureus.61917.


Ophthalmic manifestations of nasopharyngeal carcinoma (NPC): A systematic review of reported cases with and without prior history of nasopharyngeal carcinoma.

Alkatan H, Alrashed S, Maktabi A Arq Bras Oftalmol. 2024; 87(2):e20220241.

PMID: 38451680 PMC: 11620173. DOI: 10.5935/0004-2749.2022-0241.


A Distinct Anti-EBV DNase Profile in Patients with Undifferentiated Nasopharyngeal Carcinoma Compared to Classical Antigens.

Melouli H, Khenchouche A, Taibi-Zidouni F, Salma D, Aoudia N, Djennaoui D Viruses. 2023; 15(11).

PMID: 38005835 PMC: 10675439. DOI: 10.3390/v15112158.


Challenging Tumor Heterogeneity with HER2, p16 and Somatostatin Receptor 2 Expression in a Case of EBV-Associated Lymphoepithelial Carcinoma of the Salivary Gland.

Adili A, O Connor T, Wales P, Seemann M, Holler S, Hummer B Head Neck Pathol. 2023; 17(4):1052-1057.

PMID: 37847488 PMC: 10739679. DOI: 10.1007/s12105-023-01592-4.


References
1.
Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N . Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995; 333(11):693-8. DOI: 10.1056/NEJM199509143331103. View

2.
Shanmugaratnam K, Chan S, Goh J, Khor T, SIMONS M, TYE C . Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics. Cancer. 1979; 44(3):1029-44. DOI: 10.1002/1097-0142(197909)44:3<1029::aid-cncr2820440335>3.0.co;2-5. View

3.
Jenkin R, ANDERSON J, Jereb B, Thompson J, Pyesmany A, Wara W . Nasopharyngeal carcinoma--a retrospective review of patients less than thirty years of age: a report of Children's Cancer Study Group. Cancer. 1981; 47(2):360-6. DOI: 10.1002/1097-0142(19810115)47:2<360::aid-cncr2820470225>3.0.co;2-3. View

4.
Chua D, Sham J, Kwong D, Au G . Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma. Cancer. 2003; 98(1):74-80. DOI: 10.1002/cncr.11485. View

5.
BUELL P . The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res. 1974; 34(5):1189-91. View